The Journal of Molecular Medicine, Genetics and Therapeutic Research invites submissions of original, high-quality manuscripts that align with the journal’s interdisciplinary focus. Authors must ensure that their work adheres to the following guidelines before submission. Manuscripts that do not meet these standards may be returned for revision prior to peer review.

General Requirements
All manuscripts must be written in clear, concise English. Submissions should be original, unpublished, and not under consideration elsewhere. Any form of plagiarism, data fabrication, or unethical research practices will result in immediate rejection. Authors are responsible for ensuring the accuracy, transparency, and ethical compliance of their work.

Manuscript Types Accepted
• Original Research Articles
• Review Articles
• Short Communications
• Case Studies or Clinical Reports
• Methodological Papers
• Invited Editorials or Commentaries

Manuscript Formatting
Manuscripts should be submitted in Microsoft Word format, using Times New Roman (12-point font), with double spacing and standard 1-inch (2.54 cm) margins. Pages must be numbered consecutively. The text should follow a logical structure with clearly marked section headings and subheadings.

Title Page
• Full title of the manuscript (concise and descriptive)
• Names and affiliations of all authors
• Corresponding author’s name, email, and contact number
• ORCID iDs (if available)
• Short running title (maximum 50 characters)

Abstract and Keywords
• Abstract: 200-300 words summarizing the background, objectives, methodology, results, and conclusions. Structured abstracts are preferred.
• Keywords: 4 to 6 relevant keywords should be provided after the abstract.

Main Text Structure
For Original Research Articles, the standard IMRaD format is required:
• Introduction: Contextualize the study, highlight knowledge gaps, and state research objectives.
• Materials and Methods: Provide sufficient detail for reproducibility, including sample information, sequencing techniques, experimental protocols, or analytical models.
• Results: Present findings clearly with supporting figures and tables.
• Discussion: Interpret results, compare with previous studies, and highlight implications.
• Conclusion: Summarize the main findings and suggest future research directions.

Review Articles should synthesize recent developments in molecular medicine, therapeutic advances, or genetic research. Systematic reviews must follow PRISMA or other relevant reporting guidelines.

Case Studies and Clinical Reports must include background, patient information, diagnostic and therapeutic details, and clinical outcomes, with appropriate ethical approvals.

Tables and Figures
• Each figure and table must be numbered and cited in the text.
• Provide clear titles and legends for all tables and figures.
• Images must be submitted at a resolution of at least 300 dpi.
• Do not duplicate data across text, tables, and figures.

References
References should follow APA style. All in-text citations must match the references listed at the end of the manuscript. Use the author-date citation format consistently. Authors are encouraged to include DOIs where applicable.

Ethical Considerations
For studies involving human participants, cell lines, or animal models, appropriate ethical clearance must be obtained and clearly mentioned in the manuscript. Authors must confirm that informed consent was obtained where applicable. All procedures must comply with institutional, national, or international guidelines on research ethics.

Conflict of Interest
All authors must declare any financial or personal relationships that could influence the work. A conflict of interest statement is required even if there are no conflicts to declare.

Funding Statement
Include a detailed statement of all financial support received for the work, specifying funding agencies and grant numbers.

Acknowledgments
Optional acknowledgments can be included to recognize individuals, institutions, or contributors who do not meet authorship criteria.

Authorship Criteria
All listed authors should have made substantial contributions to the conception, design, execution, or interpretation of the research. The corresponding author must confirm that all authors have approved the final manuscript.

Submission Process
Manuscripts may be submitted through the journal’s online submission system or via the designated email address. Submissions must include the title page, main manuscript, tables, figures, and any supplementary material. Manuscripts not adhering to the journal’s format will be returned for correction before review.

Peer Review Process
All submissions undergo initial editorial screening followed by rigorous double-blind peer review. Reviewers are selected based on subject expertise. Authors may be asked to revise their manuscript in response to reviewer feedback. The final decision rests with the editorial board.

Copyright and Licensing
This journal follows an open-access model. Authors retain the copyright and grant the publisher permission to publish under a Creative Commons license. All published articles are freely accessible to the public upon publication.

Proofs and Corrections
Proofs will be sent to the corresponding author before publication. Authors must review and return corrected proofs promptly. Only typographical or factual corrections will be accepted at this stage.

Article Processing Charges (APC)
An Article Processing Charge (APC) is applicable only after acceptance. The APC supports editorial management, peer review, online hosting, archiving, and indexing services. There are no charges for submission. Invoices are issued post-acceptance.

Contact Information
For editorial queries or submission support, please contact the journal’s editorial office via the official email listed on the website